Page last updated: 2024-10-31

metyrapone and Gestational Luteoma

metyrapone has been researched along with Gestational Luteoma in 1 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lubin, V1
Gautier, JF1
Antoine, JM1
Beressi, JP1
Vexiau, P1

Reviews

1 review available for metyrapone and Gestational Luteoma

ArticleYear
[Cushing's syndrome during pregnancy].
    Presse medicale (Paris, France : 1983), 2002, Nov-09, Volume: 31, Issue:36

    Topics: Adrenal Cortex Neoplasms; Adult; Anti-Inflammatory Agents; Antimetabolites; Cushing Syndrome; Dexame

2002